Abbvie Inc
ABBVCompany Overview
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Shariah Compliance Benchmarks:
- Business Compliance: Non-Shariah compliant revenue must be less than 5% of total revenue
- Liabilities Compliance: Interest-bearing debt must be less than 33% of market capitalization
This stock meets all Shariah compliance criteria according to AAOIFI standards.
| Name | Abbvie Inc |
| Ticker | ABBV |
| Main Business | Pharmaceutical Preparations |
| Type | Securities |
| Industry | Drug Manufacturers—General |
| Country | US |
| Market Cap | $274.30 B |
Shariah Analysis Breakdown
| Revenue Segment | Value ($M) | Non-Compliant ($M) | Reason |
|---|---|---|---|
| Net revenues | $58,054.0 | $0.0 | All Shariah |
| Interest income | $186.0 | $186.0 | - |
| Total | $58,240.0 | $186.0 | 0.32% (passed) |
| Liability Item | Value ($M) | % of Market Cap |
|---|---|---|
| current debt and capital lease obligation | $7,190,000,000.0 | 2.62% |
| long term debt and capital lease obligation | $52,190,000,000.0 | 19.03% |
| Total Interest-Bearing Debt | $59,380,000,000.0 | 21.65% |
| Market Capitalization | $274,296,900,000.0 | 100.00% |
| Compliance Status | Threshold: 33% | passed |